相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。GPVI expression is linked to platelet size, age, and reactivity
Alicia Veninga et al.
BLOOD ADVANCES (2022)
Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype
Waltraud C. Schrottmaier et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-αIIbβ3 antibodies and thrombopoietin receptor agonists
Nobuko Nishiura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause
Dino Mehic et al.
BLOOD ADVANCES (2020)
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
Lamya Garabet et al.
PLATELETS (2019)
Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function
Eimear Dunne et al.
BLOOD (2019)
Arachidonic acid causes lysis of blood cells and ADP-dependent platelet activation responses in platelet function tests
Sofia Ramstrom
PLATELETS (2019)
Platelet function testing at low platelet counts: When can you trust your analysis?
Niklas Boknas et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Evaluation of platelet function in thrombocytopenia
Mette Tiedemann Skipper et al.
PLATELETS (2018)
Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy
Constance C. F. M. J. Baaten et al.
HAEMATOLOGICA (2018)
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
M. -L. Piel-Julian et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Platelet Function in ITP, Independent of Platelet Count, Is Consistent Over Time and Is Associated with Both Current and Subsequent Bleeding Severity
A. L. Frelinger et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy
Constance C. F. M. J. Baaten et al.
HAEMATOLOGICA (2018)
Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank
Helmuth Haslacher et al.
BIOPRESERVATION AND BIOBANKING (2018)
Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis
Julia Riedl et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Is ITP a thrombophilic disorder?
Francesco Rodeghiero
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Investigation of platelet function and platelet disorders using flow cytometry
Peter Rubak et al.
PLATELETS (2016)
Novel association of soluble intercellular adhesion molecule 1 and soluble P-selectin with the ABO blood group in a Chinese population
Wenjing Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP
Andrew L. Frelinger et al.
BLOOD (2015)
Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts
Esther R. van Bladel et al.
BLOOD (2014)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
Immune Thrombocytopenia
Gaurav Kistangari et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Platelet activation and function during eltrombopag treatment in immune thrombocytopenia
Johanna Haselboeck et al.
ANNALS OF HEMATOLOGY (2012)
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation
Bethan Psaila et al.
BLOOD (2012)
Primary Immune Thrombocytopenia in Adults - Diagnostics and Treatment Consensus Statement of the Austrian Society of Hematology and Oncology (OGHO)
Ingrid Pabinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2012)
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Marianne T. Severinsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia
B. Psaila et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
Ameet Sarpatwari et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage
Sherrill J. Slichter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases
Bethan Psaila et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Cihan Ay et al.
BLOOD (2008)
Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia
Simon Panzer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant
Cihan Ay et al.
CLINICAL CHEMISTRY (2007)
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
Julian M. Jenkins et al.
BLOOD (2007)
Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia
Simon Panzer et al.
PEDIATRIC BLOOD & CANCER (2006)
Agonists-induced platelet activation varies considerably in healthy male individuals:: studies by flow cytometry
S Panzer et al.
ANNALS OF HEMATOLOGY (2006)
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study
F Rodeghiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia
EB Leinoe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Pro-coagulant state resulting from high levels of soluble P-selecain in blood
P André et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories
P Lemez et al.
LEUKEMIA RESEARCH (2000)